Assessment of Medication Adherence Using Pharmacy Data Before and After Percutaneous Coronary Intervention.
Seifu M AberaColin O'DonnellTaufiq SalahuddinKrishna PrabhuCarol E SimonsP Michael HoStephen W WaldoJacob A DollPublished in: Patient preference and adherence (2023)
Adherence to cardiovascular medications prior to PCI can be assessed for most patients using pharmacy data, and past adherence is associated with future adherence and mortality after PCI. Use of integrated pharmacy data to identify high-risk patients could improve outcomes and cost-effectiveness of adherence interventions.
Keyphrases
- percutaneous coronary intervention
- end stage renal disease
- ejection fraction
- newly diagnosed
- coronary artery disease
- acute myocardial infarction
- chronic kidney disease
- acute coronary syndrome
- electronic health record
- peritoneal dialysis
- big data
- antiplatelet therapy
- coronary artery bypass grafting
- adipose tissue
- metabolic syndrome
- left ventricular
- skeletal muscle
- weight loss
- data analysis
- patient reported
- insulin resistance